|
| Status |
Public on Feb 16, 2017 |
| Title |
Multicomponent Signatures for Predicting Epigenomic Treatment Efficacy |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by array
|
| Summary |
Genome wide DNA methylation profiling of breast cancer cell lines and mouse xenograft, treated with HDAC Inhibitors.
|
| |
|
| Overall design |
Bisulphite converted DNA from the 48 samples were hybridised to the Illumina Infinium 450K Human Methylation Beadchip
|
| |
|
| Contributor(s) |
Bild A, Jeffrey SS |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Feb 15, 2017 |
| Last update date |
Mar 22, 2019 |
| Contact name |
William Evan Johnson |
| Organization name |
Boston University
|
| Department |
Computational Biomedicine
|
| Lab |
Johnson Lab
|
| Street address |
72 E Concord Street
|
| City |
Boston |
| State/province |
MA |
| ZIP/Postal code |
02118 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
|
| Samples (72)
|
|
| Relations |
| BioProject |
PRJNA374880 |
Less...
More...